ImageneBio IMA
NASDAQ IMA
$4.22 +0.17 (+4.20%)
At close: Oct 23, 2026 · 4:00 PM EDT

ImageneBio (IMA) Sale and Maturity of Investments (2022 - 2025)

Updated

Analysis

ImageneBio (IMA) Sale and Maturity of Investments (2022 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 ImageneBio 35.98 Mn -451.64 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 2.25 Mn
Dec 31, 2024 50.31 Mn
Sep 30, 2024 -17.05 Mn
Jun 30, 2024 13.70 Mn
Mar 31, 2024 13.50 Mn
Dec 31, 2023 45.48 Mn
Sep 30, 2023 50.06 Mn
Jun 30, 2023 28.00 Mn
Mar 31, 2023 31.07 Mn
Dec 31, 2022 37.21 Mn
Sep 30, 2022 51.78 Mn
API Access

ImageneBio Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=IMA&period=max&api_key=YOUR_API_KEY